4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-24-021198
Chief Financial Officer gave up 1,053 shares (to pay taxes)
- Chief Financial Officer acquired 4,329 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2024-06-22 | Option exercise | +4,329 | 12,416 | D: show line 1 in the form | ||
| Foster Jonathan P. Chief Financial Officer | 2024-06-22 | Shares withheld for taxes | −1,053 | $3.74 | $3,938 | 11,363 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2024-06-22 | Option exercise · Restricted Stock Units | −4,329 | 64,837 | D: show line 3 in the form |
Loading xslF345X05/rdgdoc.xml…